---
title: "Stem Cell Therapy for Crohn’s Disease: What the Research Shows and Who May Be a Candidate"
description: "An honest guide to mesenchymal stem cell (MSC) therapy for Crohn's disease: what the trials show (including a large negative one), our 300 million cell IV protocol and price, risks, and who may be a candidate."
canonical: "https://dreambody.clinic/stem-cell-therapy-crohns-disease-research/"
---

# Stem Cell Therapy for Crohn’s Disease: What the Research Shows and Who May Be a Candidate

If you’ve lived with Crohn’s disease for years, you know the cycle. A flare, a course of steroids, a new medicine that works for a while. Then another flare, another biologic, another round of tests. Maybe you’ve had a resection, or you’re managing a fistula. Somewhere along the way, you started searching for something beyond the next prescription.

That search often leads to stem cells. This guide explains what’s happening in Crohn’s disease, what standard care can do, what the published research on mesenchymal stem cells (MSCs) actually shows, exactly what our protocol involves and costs, and who may be a reasonable candidate. We’ll be straightforward with you: MSC therapy for Crohn’s disease is investigational. Some trials found modest improvements, one large trial found no benefit over placebo, and nothing here replaces the care you get from your gastroenterologist.

## What Happens in Crohn's Disease

Crohn’s disease is a chronic inflammatory bowel disease (IBD). The immune system drives ongoing inflammation in the digestive tract. It can affect any part of the gut, from the mouth to the anus, but it most often involves the end of the small intestine and the colon.

Because the inflammation can run through the full thickness of the bowel wall, Crohn’s can lead to:

- **Flares** of abdominal pain, diarrhea, fatigue and weight loss
- **Strictures**, where scarring narrows the bowel
- **Fistulas**, abnormal tunnels between the bowel and nearby skin or organs, most often around the anus (perianal fistulas)
- **Effects outside the gut**, such as joint pain, skin and eye inflammation, and anemia

Crohn’s is different from ulcerative colitis, which affects only the lining of the colon and rectum. Both are forms of IBD, and both are different from irritable bowel syndrome (IBS), which doesn’t involve this kind of inflammation.

## What Standard Care Can Do

Modern Crohn’s care has improved a lot. Depending on where and how severe the disease is, your gastroenterologist may use:

- **Corticosteroids** to calm a flare (not for long-term use)
- **Immunomodulators**, such as azathioprine or methotrexate
- **Biologics and small-molecule drugs** that target specific parts of the immune response
- **Nutrition therapy**, including specialized diets in some cases
- **Surgery** for strictures, fistulas, abscesses or bowel that’s badly damaged

These treatments help many people reach and stay in remission. But some patients lose response over time or run out of options they tolerate. That’s usually when they start reading about stem cells. If that’s you, it’s worth knowing that stem cell therapy is not a replacement for this care. At most, it’s something to discuss alongside it.

## How MSCs Are Thought to Work in Crohn's

Mesenchymal stem cells are best understood as signaling cells. They work mainly through what scientists call paracrine signaling: they release proteins and other molecules that influence the cells around them. They don’t turn into new bowel lining.

In laboratory and early clinical research, MSCs have been shown to:

- **Calm overactive immune signals** by lowering pro-inflammatory molecules and raising anti-inflammatory ones
- **Interact with immune cells**, including T cells and dendritic cells, and support regulatory T cells that help keep immune responses in check
- **Support the environment** for repair of the gut lining, which may help in areas of injury

These effects explain why researchers are interested in MSCs for Crohn’s. Lab findings, though, don’t guarantee results in patients. Effects observed in a dish or in animals often turn out smaller, or absent, in people. That’s why the human trials below matter most. Our [guide to what stem cells are](https://dreambody.clinic/what-are-stem-cells-plain-language-guide/) covers the science in more depth.

## What the Research Shows

Crohn’s has been studied with MSCs in two very different ways: injecting cells **directly into perianal fistulas**, and giving cells **by IV for inflammation in the bowel** (called luminal disease). It’s important to keep them apart, because our protocol is an IV infusion.

### Local injection for perianal fistulas

This is the most studied use. A product made from donor fat-derived MSCs (darvadstrocel, sold in Europe as Alofisel) was injected directly into fistula tracts during a surgical procedure.

- **ADMIRE-CD (2016, 212 patients):** At 24 weeks, about 50% of treated patients reached combined remission (fistulas closed with no abscess on MRI) vs about 34% with placebo. On that basis, Europe approved the product in 2018, describing the benefit as modest.
- **ADMIRE-CD II (568 patients, results reported 2023):** The larger follow-up trial found no meaningful difference. Combined remission was 48.8% with darvadstrocel vs 46.3% with placebo, and none of the secondary goals showed a benefit. No new safety concerns came up.
- **What happened next:** In December 2024, the European marketing authorization was withdrawn because the clinical benefit was no longer considered demonstrated.

We share this because it’s the clearest lesson in this field: a promising early trial didn’t hold up in a larger, better-controlled one. It’s also worth noting that this was a local injection with surgery, not an IV infusion. Its results, good or bad, don’t directly tell us what an IV protocol does.

### IV infusion for luminal Crohn’s

The evidence here is smaller.

- **Zhang et al., 2018 (82 patients, *Gut and Liver*):** Adults with moderate-to-severe Crohn’s who had been on steroids for at least six months were randomly assigned to umbilical cord MSCs (1 million cells per kilogram, by IV, once a week for four weeks) or to continue their usual care. At 12 months, the disease activity score (CDAI) fell by about 62 points in the MSC group vs about 24 points in the control group, and steroid doses dropped more. The average score in the MSC group was still about 219, above the usual remission threshold of 150. Four patients had a fever after infusion; no serious side effects were reported. The study was open-label (patients knew which group they were in) and came from a single center.
- **Small early-phase studies** of bone-marrow MSCs in hard-to-treat Crohn’s have reported mixed responses in some patients, with no large controlled trials confirming them.

**What this means in plain language:** for luminal Crohn’s, the best IV data come from one modest, open-label randomized trial showing lower symptom scores and steroid use, not remission. For fistulas, the largest trial was negative. No MSC therapy is approved by the U.S. FDA for Crohn’s disease.

### How our protocol compares

The Zhang trial gave four weekly infusions, roughly 280 million cells in total for a 70 kg adult. Our protocol is a single infusion of 300 million cells. That’s a similar total number, but no published trial has tested this exact single-dose approach for Crohn’s. We think you should know that before deciding.

## Our Crohn's Disease Protocol

Here’s exactly what we offer, as listed on our [Crohn’s disease treatment page](https://dreambody.clinic/crohns-disease-stem-cell-treatment/):

- **300 million MSCs by IV infusion.** These are allogeneic (donor) cells from Wharton’s jelly and placenta from healthy, live births, expanded in our on-site, COFEPRIS-licensed lab. Cells leave culture the day before treatment and are given within 24 hours.
- **NAD+ and high-dose vitamin C IV drip**, given after the cell infusion
- **Bloodwork reviewed by our physicians** before treatment
- **Price:** $11,500 USD, all-inclusive for the items above

Learn more about how our cells are produced and tested on our [Certified Stem Cells page](https://dreambody.clinic/certified-stem-cells/) and in our [guide to MSC science and quality](https://dreambody.clinic/science-and-quality-of-our-mesenchymal-stem-cells/).

### Your 4-day stay

- **Day 1:** Arrive in Puerto Vallarta and check in to your hotel in Bucerías or Nuevo Vallarta.
- **Day 2:** Full blood panel, reviewed by our physicians. Payment is completed at the clinic.
- **Day 3:** Stem cell IV, followed by the NAD+ and vitamin C drip. Treatment takes about two hours.
- **Day 4:** Morning check-in with the care team, then transport to the PVR airport.

After you return home, we follow up remotely at 3, 6 and 12 months. See our [travel guide](https://dreambody.clinic/travel-guide-stem-cell-treatment-bucerias/) for flights, hotels and what to pack.

## Who May Be a Candidate

Every case is reviewed individually by our physicians. You may be a reasonable candidate to discuss MSC therapy with us if you:

- Have a confirmed Crohn’s diagnosis and recent records (colonoscopy, imaging, labs)
- Have ongoing symptoms despite standard care, or have lost response to one or more medicines
- Have a gastroenterologist at home who will keep managing your care
- Are stable enough to travel and to be away from home for at least four days
- Understand that results vary and that improvement isn’t guaranteed

Our physicians may advise against treatment, or advise waiting, if you have:

- **Cancer within the past five years** (we don’t treat these patients)
- **An active infection or abscess**, including an untreated perianal abscess
- **A severe flare, suspected bowel obstruction, or significant bleeding**, which need urgent care at home, not travel
- **Significant malnutrition, dehydration or other serious organ problems** that make travel unsafe

**About your medicines:** Many people with Crohn’s take steroids, immunomodulators or biologics. Don’t stop, skip or change any of them because you’re considering stem cell therapy. Stopping these on your own can trigger a serious flare. Any changes should be decided by your own gastroenterologist.

## Risks and Side Effects

In published trials, MSC infusions have generally been well tolerated. Still, it’s a medical procedure, and you should know what to expect.

- **Fever or headache:** about 1 in 100 of our patients have a mild fever and/or headache for a few hours after treatment or the next day.
- **IV risks:** any IV carries a small risk of infection, bruising or irritation at the needle site.
- **Unknowns:** long-term data on donor MSCs in Crohn’s are limited.
- **Travel:** long flights while managing a bowel condition need planning, including bathroom access, hydration and your usual medicines.

The biggest risk may be one that’s easy to overlook: delaying or stopping effective medical care in the hope that stem cells will be enough. Please don’t.

## Questions to Ask Any Clinic

Whether you choose us or another clinic, ask:

1. What published human trials support this protocol for Crohn’s, and what did the negative ones show?
2. How is my dose chosen, and has it been tested in a trial?
3. What cell type and source do you use, and how are cells tested?
4. What happens if my bloodwork rules me out?
5. How do you coordinate with my gastroenterologist?
6. How do you follow up, and how will we know if it helped?

Our [guide to choosing a stem cell clinic](https://dreambody.clinic/how-to-choose-a-stem-cell-clinic/) covers these in more detail.

## Frequently Asked Questions

**Can stem cells cure Crohn’s disease?** No. Crohn’s is a lifelong condition. In the best IV trial, MSCs led to lower symptom scores and steroid doses on average, not remission, and the largest fistula trial showed no benefit over placebo.

**Can stem cell therapy put Crohn’s into remission?** We can’t promise that, and the published IV trial didn’t show average scores reaching remission. Some patients may notice fewer symptoms; others may notice little change.

**Will I be able to stop my biologic or steroids?** Don’t plan on it, and never stop or lower a medicine on your own. In one trial, steroid doses dropped more in the MSC group, but those changes were made by doctors. Any change should be made by your gastroenterologist.

**Do you inject stem cells into fistulas?** Our Crohn’s protocol is an IV infusion. The fistula research above used a different product given by direct injection during surgery. Ask us during your consultation if you have a fistula, and keep your colorectal surgeon involved.

**Is this the same treatment as for ulcerative colitis?** Ulcerative colitis has its own page and evidence. See our [ulcerative colitis treatment page](https://dreambody.clinic/ulcerative-colitis-stem-cell-treatment/).

**Will insurance cover it?** Insurance generally doesn’t cover stem cell therapy for Crohn’s disease, and many U.S. insurers classify it as experimental.

## Thinking About Your Options?

If you’re wondering whether MSC therapy is worth exploring alongside your current care, a free consultation is a good place to start. It’s a conversation, not a commitment. A physician will review your records and medicines, explain what the trials do and don’t show, and tell you honestly whether this may make sense for you, or whether it doesn’t.

**[Schedule your free consultation](https://dreambody.clinic/contact/)**, call (888) 704-3977, WhatsApp +52 322 232 1055, or email info@dreambodyclinic.net.

---

*Disclaimer: This article is for educational purposes and is not medical advice. Mesenchymal stem cell therapy for Crohn’s disease is investigational and is not approved by the U.S. FDA. Published human evidence is limited and mixed, results vary, and some patients see little or no benefit. Stem cell therapy offers no guarantees and is not a cure. Do not stop or change any medication without talking to your own doctor. Treatment eligibility is decided only after a review of your medical history. Dream Body Clinic is located in Bucerías, Nayarit, Mexico, and operates under the oversight of COFEPRIS, Mexico’s health regulator.*
